State of Tennessee, Department of Treasury
Position in FATE — Fate Therapeutics Inc
CIK 1587973
NASHVILLE, TN
Position in FATE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$108,000
+$19,800 QoQ
Shares Held
90,000
0.0% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026State of Tennessee, Department of Treasury holds $125,190,066 across 33 Biotechnology names. FATE ranks #33 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
81,668 | $36,468,028 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,458 | $32,032,109 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
29,581 | $5,592,288 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
91,261 | $5,155,333 | |
| 5 | EXEL |
Exelixis, Inc.
|
119,701 | $5,133,975 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
57,516 | $3,717,259 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
129,274 | $3,580,889 | |
| 8 | INCY |
Incyte Corp
|
37,020 | $3,484,322 |
All Filings in FATE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $108,000 | 90,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $88,200 | 90,000 | Shares | Sole | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||